NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.91
+0.21 (3.78%)
At close: Nov 3, 2026, 4:00 PM EST
5.91
0.00 (0.00%)
After-hours: Nov 3, 2026, 4:00 PM EST
NextCure Market Cap
NextCure has a market cap or net worth of $27.05 million as of November 3, 2026. It is the 34,804th most valuable company in the world and the 5,033rd biggest in the United States. Its market cap has decreased by 19.77% in one year.
Market Cap
27.05M
Enterprise Value
11.63M
1-Year Change
-19.77%
Global Rank
Country Rank
#5,033 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $27.05M, a decrease of -93.80%. That is a compound annual growth rate of -31.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 27.05M | -45.62% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 30.05M |
| EyePoint | 30.04M |
| Aligos Therapeutics | 29.97M |
| Aardvark Therapeutics | 29.76M |
| ProMIS Neurosciences | 29.68M |
| Metagenomi Therapeutics | 29.48M |
| Estrella Immunopharma | 27.81M |
| TransCode Therapeutics | 27.60M |